Unity Biotechnology, Inc.
UBXDelisted Aug 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Unity Biotechnology, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 66 | 72 | +6 |
| Shares | 9.42M | 61.0M | +51.6M (+547.5%) |
| Value | $5.31M | $24.1M | +$18.8M (+354.4%) |
New holders (22)
Institutions that held Unity Biotechnology, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (16)
Institutions that held Unity Biotechnology, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Gsa Capital Partners LLP | 639,937 | $361.0K |
| Pura Vida Investments, LLC | 359,089 | $202.0K |
| Caption Management, LLC | 225,000 | $127.0K |
| Two Sigma Advisers, LP | 209,400 | $118.0K |
| Susquehanna International Group, LLP | 45,551 | $26.0K |
| Two Sigma Investments, LP | 41,091 | $23.0K |
| SeaCrest Wealth Management, LLC | 25,000 | $14.0K |
| Forefront Analytics, LLC | 20,377 | $11.0K |
| Two Sigma Securities, LLC | 13,864 | $8.00K |
| Cubist Systematic Strategies, LLC | 11,563 | $7.00K |
| Squarepoint Ops LLC | 10,530 | $6.00K |
| Captrust Financial Advisors | 4,550 | $3.00K |
| TD Waterhouse Canada Inc. | 759 | $539 |
| Venture Visionary Partners LLC | 617 | $347 |
| Blue Bell Private Wealth Management, LLC | 300 | $0 |
| Lindbrook Capital, LLC | 40 | $0 |